Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

SPARTALIZUMAB vs SUFENTANIL: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

SPARTALIZUMAB vs SUFENTANIL: Safety Overview

Metric SPARTALIZUMAB SUFENTANIL
Total FAERS Reports 288 4,323
Deaths Reported 23 382
Death Rate 8.0% 8.8%
Hospitalizations 235 1,651
Average Patient Age 61.1 yrs 51.0 yrs
% Female Patients 59.2% 57.6%
FDA Approval Date N/A Dec 11, 1996
Manufacturer N/A Hikma Pharmaceuticals USA Inc.
Route N/A EPIDURAL
Marketing Status N/A Prescription